389 Phase II of CD40 agonistic antibody sotigalimab (APX005M) in combination with nivolumab in subjects with metastatic melanoma with confirmed disease progression on anti-PD-1 therapy

• Enriqueta Felip,
• Mario Sznol,
• Harriet Kluger,
• Erin Filbert,
• Valentina Boni,
• Montaser Shaheen,
• Nicholas Iannotti,
• Delvys Rodriguez-Abreu,
• Maria Gonzalez-Cao,
• Alfonso Berrocal,
• Ralph Hauke,
• Lynn Schuchter,
• Gerald Linette,
• Sarah Weiss,
• Miguel-Ángel Berciano-Guerrero,
• Ana Maria Arance,
• Apar Kishor Ganti

Affiliations

Enriqueta Felip

3Vall d’ Hebron Institute of Oncology, Barcelona, Spain

Mario Sznol

Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA

Harriet Kluger

Aff1 grid.47100.320000000419368710Yale University New Haven CT USA

Erin Filbert

Aff1 Apexigen, Inc. San Carlos CA USA

Valentina Boni

Department of Medical Oncology, START Madrid-CIOCC, Hospital Universitario HM Sanchinarro, Madrid, Spain

Montaser Shaheen

7University of Arizona, Pheonix, AZ, USA

Nicholas Iannotti

Hematology Oncology Associates of the Treasure Coast, Port St. Lucie, Florida, USA

Delvys Rodriguez-Abreu

Medical Oncology, Hospital Universitario Insular de Gran Canaria, Las Palmas, Canarias, Spain

Maria Gonzalez-Cao

Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain

Alfonso Berrocal

Oncology Department, Consorci Hospital General Universitari de Valencia, Valencia, Comunitat Valenciana, Spain

Ralph Hauke

8 Medicine, Nebraska Cancer Specialists, Omaha, Nebraska, USA

Lynn Schuchter

Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Gerald Linette

Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA

Sarah Weiss

1Yale University School of Medicine, New Haven, CT, USA

Miguel-Ángel Berciano-Guerrero

3Victoria University Hospital, Málaga, Spain

Ana Maria Arance

6Hospital Clínic Barcelona, Barcelona, Spain

Apar Kishor Ganti

11University of Nebraska Medical Center, Omaha, NE, USA